Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis

Ning Hua Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaCorrespondence[email protected]
View further author information

Xuan Gongb Outpatient Department, Chongqing General Hospital, Chongqing, ChinaView further author information

Shijie Yinc Department of Orthopaedics, The University of Hong Kong-Shenzhen Hospital, Shenzhen, ChinaView further author information

Qi Lid Department of Orthopaedics, Chongqing Beibei Traditional Chinese Medical Hospital, Chongqing, ChinaView further author information

Hao Chene Department of Orthopaedics, Chongqing Yubei People’s Hospital, Chongqing, ChinaView further author information

Yuwan Lia Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information

Feilong Lif Department of Orthopaedics, Chongqing Dazu People’s Hospital, Chongqing, ChinaView further author information

Leilei Qinga Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information

Jianye Yanga Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information

Sizheng Zhua Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information

Jiawei Wanga Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaView further author information

Junchao Lig College of Material Science and Engineering, Chongqing University, Chongqing, ChinaView further author information

Articles from other publishers (16)